Delivery Order SPE2DB22D1106-SPE2DB24FDZF7
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $24,443.70 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The delivery order is for BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 8, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger, single-award indefinite delivery contract (IDC) valued...
- The Defense Logistics Agency has awarded a $15,520.80 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The delivery order is for BEYFORTUS 100 MG/ML SYRINGEML and has a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGEML pharmaceutical products. The contract, valued at $4,656.24, has a period of performance through February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this specific award. This delivery order is part of a larger indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,104.16 delivery order is for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. This delivery order falls under a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $31,405.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,027.52 firm fixed-price delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $9,777.48 contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as a prime contractor providing a range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The $1,552.08 contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a $12,320.16 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565606321 BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of August 22, 2024 and is not a set-aside requirement. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical supplies and drugs to various federal agencies through multiple Indefinite Delivery Contracts (IDCs),...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $8,925.00 firm-fixed-price contract is for the delivery of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen, a for-profit organization, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly to military...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDZF7Delivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $32,591.60, is for the provision of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.6k | 2/8/24 |